The event, which is now firmly part of the international annual healthcare conference calendar, is attended by key industry leaders and decision makers, and brings together executives from big pharma and biotech, sell side analysts, investors and key media. ICR Consilium are delighted to once again host an engaging set of panels, to prompt discussion and enable a chance for high-quality networking.